{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:05:24Z","timestamp":1784599524616,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Discov"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Obesity and its associated metabolic complications represent a global health crisis, yet effective microbiota-targeted pharmacotherapies remain limited. Here, we report that GV-971 (sodium oligomannate), a marine-derived oligosaccharide originally developed for Alzheimer\u2019s disease, exerts potent anti-obesity and metabolic benefits by reprogramming gut microbial and host signaling networks. In high-fat diet-induced obese mice, GV-971 reduced adiposity, improved glucose homeostasis, and alleviated hepatic steatosis without affecting food intake. Multi-omics and causal intervention experiments revealed that GV-971 selectively decreased the abundance of\n                    <jats:italic>Clostridium scindens<\/jats:italic>\n                    , a keystone bacterium responsible for secondary bile acid synthesis. This decrease downregulated the expression of the\n                    <jats:italic>baiF<\/jats:italic>\n                    gene encoding 7\u03b1-hydroxysteroid dehydrogenase, leading to reduced intestinal deoxycholic acid (DCA) levels and inhibition of intestinal farnesoid X receptor (FXR) signaling. Restoration of\n                    <jats:italic>C. scindens<\/jats:italic>\n                    abundance,\n                    <jats:italic>baiF<\/jats:italic>\n                    expression, or DCA supplementation abrogated the metabolic benefits of GV-971, confirming the causal role of the\n                    <jats:italic>C. scindens<\/jats:italic>\n                    -DCA-FXR axis. Mechanistically, inhibition of intestinal FXR promoted thermogenic gene expression and white adipose tissue browning, thus enhancing systemic energy expenditure. These findings uncover a bacterium-metabolite-host signaling pathway underlying the effects of GV-971 and establish microbiota-directed FXR modulation as a promising therapeutic approach for obesity and metabolic disease.\n                  <\/jats:p>","DOI":"10.1038\/s41421-026-00904-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:00:58Z","timestamp":1784599258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GV-971 remodels the gut microbiota-bile acid-FXR axis to ameliorate obesity and metabolic dysfunction"],"prefix":"10.1038","volume":"12","author":[{"given":"Na","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yameng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6045-647X","authenticated-orcid":false,"given":"Yihan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1903-6180","authenticated-orcid":false,"given":"Daolin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3668-4830","authenticated-orcid":false,"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2220-2407","authenticated-orcid":false,"given":"Jinbao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"904_CR1","unstructured":"WHO. Obesity and overweight, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight (2024)."},{"key":"904_CR2","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022 A pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 403, 1027\u20131050 (2024)."},{"key":"904_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1053\/j.gastro.2020.10.057","volume":"160","author":"J Aron-Wisnewsky","year":"2021","unstructured":"Aron-Wisnewsky, J., Warmbrunn, M. V., Nieuwdorp, M. & Cl\u00e9ment, K. Metabolism and metabolic disorders and the microbiome: The intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies. Gastroenterology 160, 573\u2013599 (2021).","journal-title":"Gastroenterology"},{"key":"904_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"A Afshin","year":"2017","unstructured":"Afshin, A. et al. Health effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med. 377, 13\u201327 (2017).","journal-title":"N. Engl. J. Med."},{"key":"904_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2337\/db12-0443","volume":"62","author":"SB Jorgensen","year":"2013","unstructured":"Jorgensen, S. B. et al. Deletion of skeletal muscle socs3 prevents insulin resistance in obesity. Diabetes 62, 56\u201364 (2013).","journal-title":"Diabetes"},{"key":"904_CR6","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s43032-024-01502-1","volume":"31","author":"W Mai","year":"2024","unstructured":"Mai, W. et al. 1-DNJ alleviates obesity-induced testicular inflammation in mice model by inhibiting IKK\u03b2\/ NK-kB pathway. Reprod. Sci. 31, 2103\u20132113 (2024).","journal-title":"Reprod. Sci."},{"key":"904_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1017\/S0029665118002719","volume":"78","author":"F Fava","year":"2019","unstructured":"Fava, F., Rizzetto, L. & Tuohy, K. M. Gut microbiota and health: Connecting actors across the metabolic system. Proc. Nutr. Soc. 78, 177\u2013188 (2019).","journal-title":"Proc. Nutr. Soc."},{"key":"904_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/19490976.2017.1299309","volume":"8","author":"SM Donovan","year":"2017","unstructured":"Donovan, S. M. Introduction to the special focus issue on the impact of diet on gut microbiota composition and function and future opportunities for nutritional modulation of the gut microbiome to improve human health. Gut Microbes 8, 75\u201381 (2017).","journal-title":"Gut Microbes"},{"key":"904_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53832-y","volume":"15","author":"A Keshet","year":"2024","unstructured":"Keshet, A. & Segal, E. Identification of gut microbiome features associated with host metabolic health in a large population-based cohort. Nat. Commun. 15, 9358 (2024).","journal-title":"Nat. Commun."},{"key":"904_CR10","doi-asserted-by":"publisher","first-page":"1988836","DOI":"10.1080\/19490976.2021.1988836","volume":"13","author":"IS Larsen","year":"2021","unstructured":"Larsen, I. S. et al. Fungal lysozyme leverages the gut microbiota to curb dss-induced colitis. Gut Microbes 13, 1988836 (2021).","journal-title":"Gut Microbes"},{"key":"904_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000526206","volume":"15","author":"K Udompornpitak","year":"2023","unstructured":"Udompornpitak, K. et al. Obesity exacerbates lupus activity in Fc gamma receptor IIb deficient lupus mice partly through saturated fatty acid-induced gut barrier defect and systemic inflammation. J. Innate Immun. 15, 240\u2013261 (2023).","journal-title":"J. Innate Immun."},{"key":"904_CR12","doi-asserted-by":"publisher","first-page":"2377576","DOI":"10.1080\/19490976.2024.2377576","volume":"16","author":"M Li","year":"2024","unstructured":"Li, M. et al. Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation. Gut Microbes 16, 2377576 (2024).","journal-title":"Gut Microbes"},{"key":"904_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5946\/ce.2015.117","volume":"49","author":"HH Choi","year":"2016","unstructured":"Choi, H. H. & Cho, Y. S. Fecal microbiota transplantation: Current applications, effectiveness, and future perspectives. Clin. Endosc. 49, 257\u2013265 (2016).","journal-title":"Clin. Endosc."},{"key":"904_CR14","doi-asserted-by":"publisher","first-page":"1363079","DOI":"10.3389\/fnut.2024.1363079","volume":"11","author":"SV Kumbhare","year":"2024","unstructured":"Kumbhare, S. V. et al. Longitudinal gut microbial signals are associated with weight loss: Insights from a digital therapeutics program. Front. Nutr. 11, 1363079 (2024).","journal-title":"Front. Nutr."},{"key":"904_CR15","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1039\/D5FO02121A","volume":"16","author":"J Yu","year":"2025","unstructured":"Yu, J., An, N., Zhang, L., Duan, Z. & Li, J. The effect of the biofilm-forming Lactiplantibacillus plantarum F3-2 on improving lipid accumulation in vitro. Food Funct. 16, 6401\u20136410 (2025).","journal-title":"Food Funct."},{"key":"904_CR16","doi-asserted-by":"publisher","first-page":"937279","DOI":"10.3389\/fnut.2022.937279","volume":"9","author":"A Li","year":"2022","unstructured":"Li, A. et al. Polyphenol-rich oolong tea alleviates obesity and modulates gut microbiota in high-fat diet-fed mice. Front. Nutr. 9, 937279 (2022).","journal-title":"Front. Nutr."},{"key":"904_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04189-6","volume":"23","author":"J Li","year":"2025","unstructured":"Li, J. et al. Differential effects of inulin and fructooligosaccharides on gut microbiota composition and glycemic metabolism in overweight\/obese and healthy individuals: A randomized, double-blind clinical trial. BMC Med. 23, 372 (2025).","journal-title":"BMC Med."},{"key":"904_CR18","doi-asserted-by":"publisher","first-page":"1324018","DOI":"10.3389\/fimmu.2024.1324018","volume":"15","author":"TA Hediyal","year":"2024","unstructured":"Hediyal, T. A. et al. Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: An update. Front. Immunol. 15, 1324018 (2024).","journal-title":"Front. Immunol."},{"key":"904_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13195-020-00678-3","volume":"12","author":"T Wang","year":"2020","unstructured":"Wang, T. et al. A phase II randomized trial of sodium oligomannate in Alzheimer\u2019s dementia. Alzheimers Res. Ther. 12, 110 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"904_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression. Cell Res. 29, 787\u2013803 (2019).","journal-title":"Cell Res."},{"key":"904_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52398-z","volume":"15","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Gv-971 prevents severe acute pancreatitis by remodeling the microbiota-metabolic-immune axis. Nat. Commun. 15, 8278 (2024).","journal-title":"Nat. Commun."},{"key":"904_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2014.12.009","volume":"21","author":"AM Cypess","year":"2015","unstructured":"Cypess, A. M. et al. Activation of human brown adipose tissue by a \u03b23-adrenergic receptor agonist. Cell Metab. 21, 33\u201338 (2015).","journal-title":"Cell Metab."},{"key":"904_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/CRD.0b013e31829cabff","volume":"21","author":"RA Mund","year":"2013","unstructured":"Mund, R. A. & Frishman, W. H. Brown adipose tissue thermogenesis: \u03b23-adrenoreceptors as a potential target for the treatment of obesity in humans. Cardiol. Rev. 21, 265\u2013269 (2013).","journal-title":"Cardiol. Rev."},{"key":"904_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.cmet.2015.09.007","volume":"22","author":"S Kajimura","year":"2015","unstructured":"Kajimura, S., Spiegelman, B. M. & Seale, P. Brown and beige fat: Physiological roles beyond heat generation. Cell Metab. 22, 546\u2013559 (2015).","journal-title":"Cell Metab."},{"key":"904_CR25","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","volume":"148","author":"PA Dutchak","year":"2012","unstructured":"Dutchak, P. A. et al. Fibroblast growth factor-21 regulates ppar\u03b3 activity and the antidiabetic actions of thiazolidinediones. Cell 148, 556\u2013567 (2012).","journal-title":"Cell"},{"key":"904_CR26","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/nm.3361","volume":"19","author":"M Harms","year":"2013","unstructured":"Harms, M. & Seale, P. Brown and beige fat: Development, function and therapeutic potential. Nat. Med. 19, 1252\u20131263 (2013).","journal-title":"Nat. Med."},{"key":"904_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI130976","volume":"130","author":"L Zhao","year":"2020","unstructured":"Zhao, L. et al. A clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome. J. Clin. Invest. 130, 438\u2013450 (2020).","journal-title":"J. Clin. Invest."},{"key":"904_CR28","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","volume":"57","author":"J Cong","year":"2024","unstructured":"Cong, J. et al. Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8(+) T cell effector functions. Immunity 57, 876\u2013889 (2024).","journal-title":"Immunity"},{"key":"904_CR29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature24661","volume":"551","author":"D Dodd","year":"2017","unstructured":"Dodd, D. et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551, 648\u2013652 (2017).","journal-title":"Nature"},{"key":"904_CR30","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & B\u00e4ckhed, F. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. Cell 165, 1332\u20131345 (2016).","journal-title":"Cell"},{"key":"904_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.steroids.2014.04.016","volume":"86","author":"H Zhou","year":"2014","unstructured":"Zhou, H. & Hylemon, P. B. Bile acids are nutrient signaling hormones. Steroids 86, 62\u201368 (2014).","journal-title":"Steroids"},{"key":"904_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1194\/jlr.M020313","volume":"53","author":"JM Ridlon","year":"2012","unstructured":"Ridlon, J. M. & Hylemon, P. B. Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7\u03b1-dehydroxylating intestinal bacterium. J. Lipid Res. 53, 66\u201376 (2012).","journal-title":"J. Lipid Res."},{"key":"904_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr\u00f6m","year":"2016","unstructured":"Wahlstr\u00f6m, A., Sayin, S. I., Marschall, H. U. & B\u00e4ckhed, F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24, 41\u201350 (2016).","journal-title":"Cell Metab."},{"key":"904_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97\u2013101 (2013).","journal-title":"Nature"},{"key":"904_CR35","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cell.2019.01.036","volume":"176","author":"T Fu","year":"2019","unstructured":"Fu, T. et al. FXR regulates intestinal cancer stem cell proliferation. Cell 176, 1098\u20131112 (2019).","journal-title":"Cell"},{"key":"904_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01546-6","volume":"11","author":"C Huang","year":"2023","unstructured":"Huang, C. et al. Maternal western diet mediates susceptibility of offspring to crohn\u2019s-like colitis by deoxycholate generation. Microbiome 11, 96 (2023).","journal-title":"Microbiome"},{"key":"904_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1819155","volume":"12","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. Gut microbial bile acid metabolite skews macrophage polarization and contributes to high-fat diet-induced colonic inflammation. Gut Microbes 12, 1\u201320 (2020).","journal-title":"Gut Microbes"},{"key":"904_CR38","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","volume":"24","author":"L Sun","year":"2018","unstructured":"Sun, L. et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat. Med. 24, 1919\u20131929 (2018).","journal-title":"Nat. Med."},{"key":"904_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10166","volume":"6","author":"C Jiang","year":"2015","unstructured":"Jiang, C. et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat. Commun. 6, 10166 (2015).","journal-title":"Nat. Commun."},{"key":"904_CR40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","volume":"151","author":"FJ Gonzalez","year":"2016","unstructured":"Gonzalez, F. J., Jiang, C. & Patterson, A. D. An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease. Gastroenterology 151, 845\u2013859 (2016).","journal-title":"Gastroenterology"},{"key":"904_CR41","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.chom.2021.04.004","volume":"29","author":"TC Liu","year":"2021","unstructured":"Liu, T. C. et al. Western diet induces paneth cell defects through microbiome alterations and farnesoid X receptor and type I interferon activation. Cell Host Microbe 29, 988\u20131001 (2021).","journal-title":"Cell Host Microbe"},{"key":"904_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cell.2014.03.012","volume":"157","author":"RM Evans","year":"2014","unstructured":"Evans, R. M. & Mangelsdorf, D. J. Nuclear receptors, RXR, and the big bang. Cell 157, 255\u2013266 (2014).","journal-title":"Cell"},{"key":"904_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","volume":"368","author":"T Matsubara","year":"2013","unstructured":"Matsubara, T., Li, F. & Gonzalez, F. J. FXR signaling in the enterohepatic system. Mol. Cell. Endocrinol. 368, 17\u201329 (2013).","journal-title":"Mol. Cell. Endocrinol."},{"key":"904_CR44","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","volume":"21","author":"S Fiorucci","year":"2015","unstructured":"Fiorucci, S. & Distrutti, E. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends Mol. Med. 21, 702\u2013714 (2015).","journal-title":"Trends Mol. Med."},{"key":"904_CR45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","volume":"582","author":"M Funabashi","year":"2020","unstructured":"Funabashi, M. et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature 582, 566\u2013570 (2020).","journal-title":"Nature"},{"key":"904_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0039-128X(80)90115-4","volume":"35","author":"BA White","year":"1980","unstructured":"White, B. A., Lipsky, R. L., Fricke, R. J. & Hylemon, P. B. Bile acid induction specificity of 7 alpha-dehydroxylase activity in an intestinal eubacterium species. Steroids 35, 103\u2013109 (1980).","journal-title":"Steroids"},{"key":"904_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon, J. M., Harris, S. C., Bhowmik, S., Kang, D. J. & Hylemon, P. B. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 7, 22\u201339 (2016).","journal-title":"Gut Microbes"},{"key":"904_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34671-1","volume":"13","author":"Y Lei","year":"2022","unstructured":"Lei, Y. et al. Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism. Nat. Commun. 13, 6862 (2022).","journal-title":"Nat. Commun."},{"key":"904_CR49","doi-asserted-by":"publisher","first-page":"2281015","DOI":"10.1080\/19490976.2023.2281015","volume":"15","author":"A Beau","year":"2023","unstructured":"Beau, A. et al. Inhibition of intestinal FXR activity as a possible mechanism for the beneficial effects of a probiotic mix supplementation on lipid metabolism alterations and weight gain in mice fed a high fat diet. Gut Microbes 15, 2281015 (2023).","journal-title":"Gut Microbes"},{"key":"904_CR50","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41564-023-01570-0","volume":"9","author":"C Liu","year":"2024","unstructured":"Liu, C. et al. Gut commensal christensenella minuta modulates host metabolism via acylated secondary bile acids. Nat. Microbiol. 9, 434\u2013450 (2024).","journal-title":"Nat. Microbiol."},{"key":"904_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3384","volume":"4","author":"F Li","year":"2013","unstructured":"Li, F. et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat. Commun. 4, 2384 (2013).","journal-title":"Nat. Commun."},{"key":"904_CR52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225\u2013235 (2013).","journal-title":"Cell Metab."},{"key":"904_CR53","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3760","volume":"21","author":"S Fang","year":"2015","unstructured":"Fang, S. et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat. Med. 21, 159\u2013165 (2015).","journal-title":"Nat. Med."},{"key":"904_CR54","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.cmet.2021.07.007","volume":"33","author":"Q Wu","year":"2021","unstructured":"Wu, Q. et al. Intestinal hypoxia-inducible factor 2\u03b1 regulates lactate levels to shape the gut microbiome and alter thermogenesis. Cell Metab. 33, 1988\u20132003 (2021).","journal-title":"Cell Metab."},{"key":"904_CR55","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1074\/jbc.M209706200","volume":"278","author":"Y Kawamata","year":"2003","unstructured":"Kawamata, Y. et al. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278, 9435\u20139440 (2003).","journal-title":"J. Biol. Chem."},{"key":"904_CR56","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1021\/jm7015864","volume":"51","author":"H Sato","year":"2008","unstructured":"Sato, H. et al. Novel potent and selective bile acid derivatives as tgr5 agonists: Biological screening, structure-activity relationships, and molecular modeling studies. J. Med. Chem. 51, 1831\u20131841 (2008).","journal-title":"J. Med. Chem."},{"key":"904_CR57","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","volume":"284","author":"M Makishima","year":"1999","unstructured":"Makishima, M. et al. Identification of a nuclear receptor for bile acids. Science 284, 1362\u20131365 (1999).","journal-title":"Science"},{"key":"904_CR58","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000450908","volume":"35","author":"FJ Gonzalez","year":"2017","unstructured":"Gonzalez, F. J., Jiang, C., Xie, C. & Patterson, A. D. Intestinal farnesoid x receptor signaling modulates metabolic disease. Dig. Dis. 35, 178\u2013184 (2017).","journal-title":"Dig. Dis."},{"key":"904_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-physiol-031620-093815","volume":"83","author":"B Chaurasia","year":"2021","unstructured":"Chaurasia, B. & Summers, S. A. Ceramides in metabolism: Key lipotoxic players. Annu. Rev. Physiol. 83, 303\u2013330 (2021).","journal-title":"Annu. Rev. Physiol."},{"key":"904_CR60","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","volume":"7","author":"TM Loo","year":"2017","unstructured":"Loo, T. M. et al. Gut microbiota promotes obesity-associated liver cancer through pge(2)-mediated suppression of antitumor immunity. Cancer Discov. 7, 522\u2013538 (2017).","journal-title":"Cancer Discov."}],"container-title":["Cell Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41421-026-00904-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-026-00904-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-026-00904-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T02:01:00Z","timestamp":1784599260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41421-026-00904-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1038\/s41421-026-00904-6","relation":{},"ISSN":["2056-5968"],"issn-type":[{"value":"2056-5968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"53"}}